About The Stroke Collaborative Action Network
A stroke happens every 45 seconds in the US, adding up to an incidence of 800,000 per year. Stroke is the fourth leading cause of death, and yet 75% percent of patients survive. The annual cost of stroke in the US is 39 billion in 2009 dollars. Furthermore, aside from clot-busting therapies that reverse or ameliorate a stroke within hours, there are no proven treatments. Of the 6,800,000 adult stroke survivors currently living in the US, one third to one half are left with a disability. This makes stroke a leading cause of disability in the US and worldwide. Quality of life also declines significantly after stroke due to functional decline, fatigue and depression.
A Stanford Neurosciences Institute Collaborative Stroke Network focused on improving the function and quality of life of stroke survivors.
Stanford is uniquely suited to bridging the barriers between basic science, engineering, and clinical research, and to thus advance stroke science. We are a leader in neuroscience, engineering, and innovation, and our network will contain a large group of outstanding investigators who are interested in stroke, highly collaborative, and span a wide range of fields. The individuals who have committed to joining the collaborative network bring expertise in a wide spectrum of science, including mechanical, electrical, and bio-engineering, systems and molecular neuroscience, imaging/radiology, neuroimmunology, neurology, neurosurgery, and genetics. Many of these fields have experienced recent advancements that have yet to be applied to stroke.
Stanford is also already a worldwide leader in clinical and translational stroke research, as well as in stroke patient care. The Stanford Stroke Center, founded in 1992, is widely recognized as a leader in clinical and experimental research with a particular emphasis on treatment trials, novel MRI techniques for early detection, moving laboratory discoveries into the clinic (such as mild hypothermic neuroprotection) and patient selection for therapies. We were designated the first comprehensive stroke center in the United States, and in 2013 we were designated by NINDS as a clinical trials coordinating center for stroke. Stanford is currently building a new outpatient clinic building that will contain stroke clinic and rehabilitation facilities.
Our Neuroscience Institute-sponsored network will bring together the basic and clinical scientists that are already here at Stanford, and potentially recruit others to fill gaps in knowledge. The network is unique–there is no such research initiative at any other university or research institute. Together, the network will define the big picture questions most likely to ultimately help stroke survivors. Acceleration of stroke research at Stanford will occur via support of “flagship” projects, training programs, and seminar series. Networking within the group will also provide collaborative opportunities, break down communication barriers between clinical and basic scientists, and facilitate solutions to fundamental scientific questions relevant to stroke.
Stanford Neurosciences Institute
The Stroke Collaborative Action Network is part of Stanford Neurosciences Institute